They probably could but you also have to consider that a substantial part of initial launch goes for stock; not all is sold near term thus the next few batches would go to replenish stock and if the product is a laggard the demand may be less, definitely less than the initial stock order. Obviously if the drug establishes a high demand such as M&M did, then .......
News 
Market Data 
Discover 
AI
